Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Hum Immunol. 2010 Jun 20;71(9):865–873. doi: 10.1016/j.humimm.2010.06.008

Table 1.

Demographic and clinical characteristics of study subjects.

KD IVIG-Responsive

(n=12)
KD IVIG-Resistant

(n=8)
Healthy
Controls
(n=9)

Age at Onset, yr 3.29
(0.33-9)
1.85
(0.33-4.92)
1.65
(0.39-4.47)
Male, n (%) 5 (42) 5 (63) 3 (33)
Illness Day at
sample collection
6
(4-10)
5
(4-7)
NA
Ethnicity/Race, n
(% of total)
 Asian 1 (8.3) 0 0
 Caucasian 4 (33) 2 (25) 3 (33)
 Hispanic 3 (25) 4 (50) 3 (33)
 Mixed 4 (33) 2 (25) 3 (33)
Coronary Artery 8 Normal 3 Normal NA
Statusa 4 Dilated 3 Dilated
2 Aneurysms
White blood cells
× 103/mm3
13.3
(5.9-23)
13.0
(7.6-19.2)
NA
Neutrophils, % 57
(22-76)
54
(28-73)
NA
Bands, % 8
(0-28)
17
(0-50)
NA
Absolute 8303 9888 NA
Neutrophil Count (4818-16269) (4302-14976)
Lymphocytes, % 17
(5-70)
18
(2-34)
NA
Monocytes, % 4.5
(0-17)
5
(2-10)
NA
zHemoglobinb −0.73
(−4.33-1)
−1.40
(−5.83-0)
NA
Erythrocyte 59.5 63.5 NA
Sedimentation (27-140) (40-140)
Rate, mm/h
C Reactive 5.5 18 NA
Protein, mg/dL (0.3-18.4) (5.1-44.2)
Platelets ×
103/mm3
404
(89-541)
394
(85-516)
NA
Alanine 69 12.5 NA
Aminotransferase, U/L (6-725) (24-161)
Gamma Glutamyl 64 109.5 NA
Transferase, U/L (9-220) (6-216)

All data presented as median (range).

a

Only significant difference between IVIG-responsive and –resistant KD subjects, p=0.04 chi square test

b

zHemoglobin, standard deviation units from the mean based on age-adjusted normal values [44] NA= not available